Xenon Pharmaceuticals XENE Unveils Robust Azetukalner Phase III Data Q3 NDA Filing Plans at Bloom Burton Conference LFACW Leapfrog details updated SPAC merger target evaluation progress in its latest quarterly earnings filing BRRWW ProCap CEO signals cautious longterm growth outlook while discussing latest quarterly earnings results WHWK Whitehawk Therapeutics falls 336 as Q4 2025 EPS misses estimates by a wide 1164 percent margin Selective SIGIP Stock Entry Timing Analysis Q1 2026 Below Expectations BAM Brookfield AM posts Q4 2025 six percent EPS beat shares slip slightly on mild investor caution